USE OF BASAL INSULIN-GLP1 COMBINATION FOR THERAPEUTIC SIMPLIFICATION IN TYPE 2 DIABETIC PATIENTS WITH A BASAL-BOLUS OR BASAL PLUS SCHEME

被引：0
|
作者：
Jaramillo-Nieto, A. [1 ]
Gomez Hernandez, I. [1 ]
Tique, C. [1 ]
机构：
[1] Fdn Santa Fe Bogota, Endocrinol, Bogota, Colombia
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2022年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
EP237 / #4
引用
收藏
页码：A180 / A180
页数：1
相关论文
共 50 条
  • [1] Basal Plus Basal-Bolus Approach in Type 2 Diabetes
    Javier Ampudia-Blasco, F.
    Rossetti, Paolo
    Ascaso, Juan F.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2011, 13 : S - 75
  • [2] Switching From Insulin Bolus Treatment to GLP-1 RAs Added to Continued Basal Insulin in People With Type 2 Diabetes on Basal-Bolus Insulin
    Bolli, Geremia B.
    Porcellati, Francesca
    Meier, Juris J.
    DIABETES CARE, 2020, 43 (10) : 2333 - 2335
  • [3] Feasibility of Simplification From a Basal-Bolus Insulin Regimen to a Fixed-Ratio Formulation of Basal Insulin Plus a GLP-1RA or to Basal Insulin Plus an SGLT2 Inhibitor: BEYOND, a Randomized, Pragmatic Trial
    Giugliano, Dario
    Longo, Miriam
    Caruso, Paola
    Di Fraia, Rosa
    Scappaticcio, Lorenzo
    Gicchino, Maurizio
    Petrizzo, Michela
    Bellastella, Giuseppe
    Maiorino, Maria Ida
    Esposito, Katherine
    DIABETES CARE, 2021, 44 (06) : 1353 - 1360
  • [4] An economic assessment of analogue basal-bolus insulin versus human basal-bolus insulin in subjects with type 1 diabetes in the UK
    Palmer, Andrew J.
    Valentine, William J.
    Ray, Joshua A.
    Foos, Volker
    Lurati, Francesco
    Smith, Inger
    Lammert, Morten
    Roze, Stephane
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (04) : 895 - 901
  • [5] Randomized Study Comparing a Basal-Bolus With a Basal Plus Correction Insulin Regimen for the Hospital Management of Medical and Surgical Patients With Type 2 Diabetes Basal Plus Trial
    Umpierrez, Guillermo E.
    Smiley, Dawn
    Hermayer, Kathie
    Khan, Amna
    Olson, Darin E.
    Newton, Christopher
    Jacobs, Sol
    Rizzo, Monica
    Peng, Limin
    Reyes, David
    Pinzon, Ingrid
    Fereira, Maria Eugenia
    Hunt, Vicky
    Gore, Ashwini
    Toyoshima, Marcos T.
    Fonseca, Vivian A.
    DIABETES CARE, 2013, 36 (08) : 2169 - 2174
  • [6] THE COSTS OF INTENSIFICATION FROM BASAL INSULIN TO BASAL-BOLUS IN TYPE 2 DIABETES: A SURVEY OF PHYSICIANS
    Pfeiffer, K. M.
    Basse, A.
    Brod, M.
    VALUE IN HEALTH, 2018, 21 : S74 - S74
  • [7] Proportion and characteristics of patients with type 2 diabetes initiating basal insulin therapy with a basal-bolus regimen in China
    Zhang, Puhong
    Zhang, Heng
    Zhu, Dongshan
    Li, Xian
    Ji, Jiachao
    Zhao, Fang
    Lu, Juming
    Jia, Weiping
    Ji, Linong
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2018, 34
  • [8] GLP-1 receptor agonist added to insulin versus basal-plus or basal-bolus insulin therapy in type 2 diabetes: A systematic review and meta-analysis
    Castellana, Marco
    Cignarelli, Angelo
    Brescia, Francesco
    Laviola, Luigi
    Giorgino, Francesco
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2019, 35 (01)
  • [9] An Indirect Comparison of Basal Insulin Plus Once-Weekly Semaglutide and Fully Optimised Basal-Bolus Insulin in Type 2 Diabetes
    Lingvay, Ildiko
    Catarig, Andrei-Mircea
    Lawson, Jack
    Chubb, Barrie
    Gorst-Rasmussen, Anders
    Evans, Lyndon Marc
    DIABETES THERAPY, 2023, 14 (01) : 123 - 137
  • [10] Use of insulin degludec, a new basal insulin with an ultra-long duration of action, in basal-bolus therapy in type 1 and type 2 diabetes
    Kerlan, Veronique
    Gouet, Didier
    Marre, Michel
    Renard, Eric
    ANNALES D ENDOCRINOLOGIE, 2013, 74 (5-6) : 487 - 490
12345